Invention Grant
- Patent Title: Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries
- Patent Title (中): 抑制CD95配体/受体系统治疗神经系统疾病和损伤
-
Application No.: US10545231Application Date: 2004-02-10
-
Publication No.: US07935339B2Publication Date: 2011-05-03
- Inventor: Ana Martin-Villalba , Peter Krammer , Deana Demjen
- Applicant: Ana Martin-Villalba , Peter Krammer , Deana Demjen
- Applicant Address: DE Heidelberg
- Assignee: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
- Current Assignee: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
- Current Assignee Address: DE Heidelberg
- Agency: Millen, White, Zelano, Branigan, P.C.
- Priority: EP03003426 20030214
- International Application: PCT/EP2004/001233 WO 20040210
- International Announcement: WO2004/071528 WO 20040826
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention relates to the use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament for the treatment of neurological disorders or injuries in a mammal, particularly for the treatment of spinal cord injury, more particularly for the treatment of paraplegia.
Public/Granted literature
- US20060234968A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries Public/Granted day:2006-10-19
Information query
